Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04248335 · ClinicalTrials.gov registry record · Phase 4

Effect of Obesity on Proton Pump Inhibitors

A Phase 4 study, sponsored by Children's Mercy Hospital Kansas City.

Completed
Registry status
Phase 4
Development phase
76
Enrollment target

NCT04248335: Completed Phase 4 study, sponsored by Children's Mercy Hospital Kansas City.

NCT04248335 is a Phase 4 study that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 76 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04248335, a Phase 4 study, has completed, sponsored by Children's Mercy Hospital Kansas City.

COMPLETED
Registry status
Phase 4
Development phase
76 participants
Enrollment target

Study Summary

This longitudinal study tests the hypothesis that obesity affects drug pharmacology of acid suppression medications in children.

Primary Outcome

plasma elimination 1/2 life (t1/2)

Interventions

  • DRUG Midazolam
  • DRUG Pantoprazole
  • DRUG Lansoprazole

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2018-07-03
Est. Completion 2024-12-31
Phase Phase 4

What the finished NCT04248335 record still lists

NCT04248335 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 3 interventions - of which Midazolam is the first listed.

NCT04248335 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04248335 about?

NCT04248335 is a clinical study titled "Effect of Obesity on Proton Pump Inhibitors". This longitudinal study tests the hypothesis that obesity affects drug pharmacology of acid suppression medications in children.

What is the current status of trial NCT04248335?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 76 participants. The study started on 2018-07-03. Estimated completion is 2024-12-31.

What interventions are being tested in trial NCT04248335?

The interventions under investigation include: Midazolam (DRUG), Pantoprazole (DRUG), Lansoprazole (DRUG).

Who is sponsoring clinical trial NCT04248335?

This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04248335's enrollment target sits among peer trials

76 994th of 2000 higher than 999 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02615184 · 76 participants · Phase 2

    A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old

  • NCT02821741 · 76 participants · NA

    Effects of External Ear Stimulation on Pain Perception and Mood

  • NCT03019757 · 76 participants

    Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

  • NCT03353584 · 76 participants · NA

    Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04248335, the US trial registry maintained by the National Library of Medicine. NCT04248335 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.